Haematology

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


788 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | ...
 
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Blum S., Chalandon Y., Labopin M., Finke J., Gedde-Dahl T., Othman T.B., Cornelissen J.J., Jindra P., Labussière-Wallet H., Collin M. et al. Haematologica. Peer-reviewed.
 
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Chalandon Y., Rousselot P., Chevret S., Cayuela J.M., Kim R., Huguet F., Chevallier P., Graux C., Thiebaut-Bertrand A., Chantepie S.P. et al. Blood. Peer-reviewed.
 
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Drozd-Sokolowska J., Gras L., Koster L., Martino R., Salas M.Q., Salmenniemi U., Zudaire T., Yañez L., Bellido M., Collin M. et al. Haematologica. Peer-reviewed.
 
Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates
Muret Charlotte, Crettaz David, Alberio Lorenzo, Prudent Michel Transfusion Medicine and Hemotherapy. Peer-reviewed.
 
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban.
Pereira Portela C., Stirnimann G., Kröll D., Aliotta A., Veuthey L., Zermatten M.G., Alberio L., Bertaggia Calderara D. Thrombosis research. Peer-reviewed.
 
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.
Saadat A., Gouttenoire J., Ripellino P., Semela D., Amar S., Frey B.M., Fontana S., Mdawar-Bailly E., Moradpour D., Fellay J. et al. Hepatology. Peer-reviewed.
 
Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R., Bisig B., Guey B., Missiaglia E., Cairoli A., Omoumi P., Letovanec I., Ferry J.A., Hasserjian R.P., de Leval L. Modern pathology. Peer-reviewed.
 
Bleeding heralding the diagnosis of essential thrombocythemia.
Stalder G., Grandoni F., Alberio L. European journal of internal medicine. Peer-reviewed.
Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy".
Schapira M., Koury M.J., Roberts I., 2024/04/10. Swiss medical weekly, 154 p. 3829. Peer-reviewed.
 
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment.
Costamagna G., Navi B.B., Beyeler M., Hottinger A.F., Alberio L., Michel P., 2024/04. Seminars in thrombosis and hemostasis, 50 (3) pp. 342-359. Peer-reviewed.
 
Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
Spertini C., Bénéchet A.P., Birch F., Bellotti A., Román-Trufero M., Arber C., Auner H.W., Mitchell R.A., Spertini O., Smirnova T., 2024/03/28. Cell death discovery, 10 (1) p. 157. Peer-reviewed.
 
Deep blue.
Dereme J., Segot A., 2024/03/21. Blood, 143 (12) p. 1198. Peer-reviewed.
 
Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
Zlamal J., Aliotta A., Alberio L., Chen V., Bakchoul T., SSC Platelet Immunology of the ISTH, 2024/03. Journal of thrombosis and haemostasis, 22 (3) pp. 860-868. Peer-reviewed.
 
Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript.
Dereme J., Voruz S., Solly F., Schoumans J., Blum S., 2024/03. Annals of hematology, 103 (3) pp. 1027-1029. Peer-reviewed.
 
Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
Afanasiev V., Tsouni P., Kuntzer T., Cairoli A., Delmont E., Vallat J.M., Devaux J., Théaudin M., 2024/03. Journal of the peripheral nervous system, 29 (1) pp. 116-119. Peer-reviewed.
 
Two to tango: engineered T cells against AML.
Arber C., 2024/02/08. Blood, 143 (6) pp. 476-478. Peer-reviewed.
 
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification.
Nachtkamp K., Strupp C., Vukelja M., Kasprzak A., Haase D., Ganster C., Hildebrandt B., Betz B., Giagounidis A., Aul C. et al., 2024/02. Leukemia, 38 (2) pp. 442-445. Peer-reviewed.
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.
Pritchard J.E., Pearce J.E., Snoeren IAM, Fuchs SNR, Götz K., Peisker F., Wagner S., Benabid A., Lutterbach N., Klöker V. et al., 2024/01/23. Cell reports, 43 (1) p. 113608. Peer-reviewed.
 
Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses.
Shehwar D., Barki S., Aliotta A., Veuthey L., Bertaggia Calderara D., Alberio L., Alam M.R., 2024/01/22. Molecular biology reports, 51 (1) p. 177. Peer-reviewed.
 
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
Passweg J.R., Baldomero H., Ansari M., Arber C., Chalandon Y., Daskalakis M., Diepold M., Diesch-Furlanetto T., Duchosal M.A., Gerull S. et al., 2024/01. Hematological oncology, 42 (1) pp. e3241. Peer-reviewed.
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L., Esteban O., Wesche J., Dobosz P., Broto M., Puig S.R., Fuhrmann J., Torres R., Serra J., Llevadot R. et al., 2023/12/28. Blood, 142 (26) pp. 2305-2314. Peer-reviewed.
MarrowCellDLD: a microfluidic method for label-free retrieval of fragile bone marrow-derived cells.
Porro G., Sarkis R., Obergozo C., Godot L., Amato F., Humbert M., Naveiras O., Guiducci C., 2023/12/18. Scientific reports, 13 (1) p. 22462. Peer-reviewed.
 
Invariant finding of non-clonal bone marrow lymphocytosis, with increased B cell component, in indolent systemic mastocytosis.
Papadopoulou V., Barcena-Garcia C., Basset V., Schoumans J., de Leval L., Schaller M., 2023/12. International journal of laboratory hematology, 45 (6) pp. 1007-1010. Peer-reviewed.
Refined cytogenetic IPSS-R evaluation by the use of SNP array in a cohort of 290 MDS patients.
Scarpelli I., Stalder V.B., Tsilimidos G., Rapakko K., Costanza M., Blum S., Schoumans J., 2023/12. Genes, chromosomes & cancer, 62 (12) pp. 721-731. Peer-reviewed.
 
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.
Papadopoulou V., Schoumans J., Basset V., Solly F., Pasquier J., Blum S., Spertini O., 2023/12. Hematology, 28 (1) p. 2180704. Peer-reviewed.
 
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R., Bergugnat H., Pastoret C., Pasquier F., Raffoux E., Larcher L., Passet M., Grardel N., Delabesse E., Kubetzko S. et al., 2023/11/23. Blood, 142 (21) pp. 1806-1817. Peer-reviewed.
 
Effets secondaires des inhibiteurs de tyrosine kinase dans la leucémie myéloïde chronique [Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia]
Dereme J., Ségot A., Friedrich N., Tsilimidos G., Blum S., 2023/11/15. Revue medicale suisse, 19 (850) pp. 2175-2181. Peer-reviewed.
 
Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?]
Choffat D., Legardeur H., Grandoni F., Alberio L., Surbone A., Baud D., Gavillet M., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1911-1914. Peer-reviewed.
 
Comparative analysis of automated cell counts in oncological patients: Reliable results of point of care blood impedance measurements and pitfalls in myelodysplastic neoplasias and acute myeloid leukemias.
Blum S., Costanza M., Coutaz C., Naveiras O., Spertini O., Tsilimidos G., Alberio L., 2023/10. International journal of laboratory hematology, 45 (5) pp. 818-821. Peer-reviewed.
 
Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A.
Bertaggia Calderara D., Marchi Cappelletti R., Batista Mesquita Sauvage A.P., Durual S., Gomez F.J., Zermatten M.G., Aliotta A., Casini A., Alberio L., 2023/10. Thrombosis and haemostasis, 123 (10) pp. 955-965. Peer-reviewed.
Pseudo-macrocytosis in chronic lymphocytic leukaemia.
Costanza M., Coutaz C., Cairoli A., Gavillet M., 2023/10. International journal of laboratory hematology, 45 (5) pp. 623-624. Peer-reviewed.
 
Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland.
Schimanski B., Kräuchi R., Stettler J., Lejon Crottet S., Niederhauser C., Clausen F.B., Fontana S., Hodel M., Amylidi-Mohr S., Raio L. et al., 2023/09/27. Biomedicines, 11 (10). Peer-reviewed.
 
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
Tsilimidos G., Blum S., 2023/09. Annals of hematology, 102 (9) pp. 2619-2620. Peer-reviewed.
Induction of mitochondrial recycling reverts age-associated decline of the hematopoietic and immune systems.
Girotra M., Chiang Y.H., Charmoy M., Ginefra P., Hope H.C., Bataclan C., Yu Y.R., Schyrr F., Franco F., Geiger H. et al., 2023/09. Nature aging, 3 (9) pp. 1057-1066. Peer-reviewed.
 
Reductive carboxylation epigenetically instructs T cell differentiation.
Jaccard A., Wyss T., Maldonado-Pérez N., Rath J.A., Bevilacqua A., Peng J.J., Lepez A., Von Gunten C., Franco F., Kao K.C. et al., 2023/09. Nature, 621 (7980) pp. 849-856. Peer-reviewed.
 
Développements récents en hématologie, Partie 2
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/23. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Développements récents en hématologie, Teil 1
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
 
Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH
Josefsson Emma C., Ramström Sofia, Thaler Johannes, Lordkipanidzé Marie, Agbani Ejaife O., Alberio Lorenzo, Bakchoul Tamam, Bouchard Beth A., Camera Marina, Chen Vivien et al., 2023/08. Journal of Thrombosis and Haemostasis, 21 (8) pp. 2291-2299.
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology.
Angelillo-Scherrer A., Casini A., Studt J.D., Gerber B., Alberio L.A., Fontana P., 2023/07/26. Swiss medical weekly, 153 p. 40113. Peer-reviewed.
 
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
Silzle T., Blum S., Kasprzak A., Nachtkamp K., Rudelius M., Hildebrandt B., Götze K.S., Gattermann N., Lauseker M., Germing U., 2023/07/11. Cancers, 15 (14) p. 3572. Peer-reviewed.
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator.
Burger A., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2023/06/20. Diagnostics, 13 (12) p. 2128. Peer-reviewed.
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Hilberink J.R., van Zeventer I.A., Chitu D.A., Pabst T., Klein S.K., Stussi G., Griskevicius L., Valk PJM, Cloos J., van de Loosdrecht A.A. et al., 2023/06/19. Blood cancer journal, 13 (1) p. 93. Peer-reviewed.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Sibon D., Bisig B., Bonnet C., Poullot E., Bachy E., Cavalieri D., Fataccioli V., Bregnard C., Drieux F., Bruneau J. et al., 2023/06/01. Haematologica, 108 (6) pp. 1590-1603. Peer-reviewed.
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) [Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)]
Miesbach W., Oldenburg J., Klamroth R., Eichler H., Koscielny J., Holzhauer S., Holstein K., Hovinga JAK, Alberio L., Olivieri M. et al., 2023/06. Hamostaseologie, 43 (3) pp. 196-207. Peer-reviewed.
 
Simultaneous kinetics of oral vorinostat in plasma and cerebrospinal fluid in a patient with cutaneous T-cell lymphoma with CNS involvement.
Papadopoulou V., Degrauwe N., Decosterd L.A., Buclin T., Cairoli A., 2023/06. International journal of clinical pharmacology and therapeutics, 61 (6) pp. 270-272. Peer-reviewed.
Computational design of dynamic receptor-peptide signaling complexes applied to chemotaxis.
Jefferson R.E., Oggier A., Füglistaler A., Camviel N., Hijazi M., Villarreal A.R., Arber C., Barth P., 2023/05/19. Nature communications, 14 (1) p. 2875. Peer-reviewed.
 
Thyroid fine needle aspiration for the diagnosis of Langerhans Cell Histiocytosis of the suprasellar region
Sciotto-Canel Lucie, Lopes Stephanie Andrade, Caironi Verdiana, Saiji Essia, Vargas Maria-Isabelle, Jornayvaz Francois R, Momjian Shahan, Stalder Gregoire, Leboulleux Sophie, Mavromati Maria, 2023/05/02. Endocrine Abstracts. Peer-reviewed.
 
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial.
Kröll D., Nett P.C., Rommers N., Borbély Y., Deichsel F., Nocito A., Zehetner J., Kessler U., Fringeli Y., Alberio L. et al., 2023/05/01. JAMA network open, 6 (5) pp. e2315241. Peer-reviewed.
Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
Gavillet M., Rufer N., Grandoni F., Rizzi M., Vulliemoz N., Baud D., Alberio L., Canellini G., Legardeur H., 2023/05. British journal of haematology, 201 (3) pp. 581-584. Peer-reviewed.
 
Role of Bcl-2 inhibition in myelodysplastic syndromes.
Blum S., Tsilimidos G., Bresser H., Lübbert M., 2023/04/15. International journal of cancer, 152 (8) pp. 1526-1535. Peer-reviewed.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
 
Eosinophilic myocarditis during treatment of acute myeloid leukaemia: cardiac magnetic resonance in the very early phase mimicking triple-vessel coronary artery disease: a case report.
Salihu A., Stadelmann R., Solimando E., Schwitter J., 2023/04. European heart journal. Case reports, 7 (4) pp. ytad185. Peer-reviewed.
Identification of High Platelet Reactivity Despite ADP P2Y12 Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve.
Mariethoz C., Scala E., Matthey-Guirao E., Rossel J.B., Gomez F.J., Grandoni F., Marcucci C., Alberio L., 2023/04. TH open, 7 (2) pp. e143-e154. Peer-reviewed.
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
Sarkis R., Burri O., Royer-Chardon C., Schyrr F., Blum S., Costanza M., Cherix S., Piazzon N., Barcena C., Bisig B. et al., 2023/04. Modern pathology, 36 (4) p. 100088. Peer-reviewed.
Ré-irradiation de compression médullaire sur foyer d’hématopoïèse extra médullaire : présentation d’un cas [Re-irradiation of bone marrow compression on a focus of extra medullary hematopoiesis: Presentation of a case]
Bernard G., Bennassi A., Dereme J., Ozsahin M., Kinj R., 2023/04. Cancer radiotherapie, 27 (2) pp. 158-162. Peer-reviewed.
Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer.
Fratta S., Biniecka P., Moreno-Vargas A.J., Carmona A.T., Nahimana A., Duchosal M.A., Piacente F., Bruzzone S., Caffa I., Nencioni A. et al., 2023/03/15. European journal of medicinal chemistry, 250 p. 115170. Peer-reviewed.
 
Shall we rethink the timing of epidural anesthesia in anticoagulated obstetrical patients?
Legardeur H., Cuenoud A., Panchaud A., Grandoni F., Mesquita Sauvage A.B., Alberio L., Baud D., Gavillet M., 2023/03. American journal of obstetrics and gynecology, 228 (3) pp. 257-260. Peer-reviewed.
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Biniecka P., Matsumoto S., Belotti A., Joussot J., Bai J.F., Majjigapu S.R., Thoueille P., Spaggiari D., Desfontaine V., Piacente F. et al., 2023/02/16. Molecules, 28 (4) p. 1897. Peer-reviewed.
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report.
Stalder G., Chatte A., De Rossi N., Yerly P., Alberio L., Eeckhout E., 2023/02. European heart journal. Case reports, 7 (2) pp. ytac497. Peer-reviewed.
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia.
Matsumoto S., Biniecka P., Bellotti A., Duchosal M.A., Nahimana A., 2023/01/27. Cancers, 15 (3) p. 787. Peer-reviewed.
 
Acquired Clotting Factor Deficits During Treatment with Asparaginase in an Institutional Cohort.
Papadopoulou V., Schiavini G., 2023. Journal of blood medicine, 14 pp. 569-574. Peer-reviewed.
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
Papadopoulou V., Schoumans J., Scarpelli I., Blum S., 2023. Acta haematologica, 146 (5) pp. 401-407. Peer-reviewed.
 
Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.
Stalder G., Da Silva W.R., Segot A., Blum S., Grandoni F., Alberio L., 2023/01. European journal of internal medicine, 107 pp. 110-112. Peer-reviewed.
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Veloza L., Cavalieri D., Missiaglia E., Ledoux-Pilon A., Bisig B., Pereira B., Bonnet C., Poullot E., Quintanilla-Martinez L., Dubois R. et al., 2023/01/01. Haematologica, 108 (1) pp. 181-195. Peer-reviewed.
 
Perioperative Management of a Patient With Combined Bernard Soulier syndrome and Storage Pool Disease During On-Pump Cardiac Surgery.
Christophel-Plathier E., Costanza M., Kirsch M., Dulguerov F., Chapuis-Bernasconi C., Bisig B., Verdy F., Mendes V., Rancati V., Alberio L. et al., 2023/01. Journal of cardiothoracic and vascular anesthesia, 37 (1) pp. 90-95. Peer-reviewed.
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Stalder G., Suffiotti M., Segot A., Noto A., Pantaleo G., Spertini O., Obeid M., 2023/01/01. Haematologica, 108 (1) pp. 234-239. Peer-reviewed.
Thrombophilia and outcomes of venous thromboembolism in older patients.
Méan M., Breakey N., Stalder O., Alberio L., Limacher A., Angelillo-Scherrer A., Fontana P., Beer H.J., Rodondi N., Aujesky D. et al., 2023/01. Research and practice in thrombosis and haemostasis, 7 (1) p. 100015. Peer-reviewed.
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma.
Bohler J., Bacher U., Banz Y., Stadelmann R., Medinger M., Zander T., Pabst T., 2022/12/21. Cancers, 15 (1) p. 44. Peer-reviewed.
 
Gene therapy of Haemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH) [Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)]
Miesbach W., Oldenburg J., Klamroth R., Eichler H., Koscielny J., Holzhauer S., Holstein K., Hovinga JAK, Alberio L., Olivieri M. et al., 2022/12/21. Hamostaseologie, 43 (3) pp. 196-207. Peer-reviewed.
 
HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.
Christe L., Veloza L., Gros L., Bisig B., Blum S., Hewer E., de Leval L., 2022/12. Diagnostic cytopathology, 50 (12) pp. E351-E356. Peer-reviewed.
 
Une rare cause de polyarthrite érosive
Alexe Roxana, Zambaz Camille, Dan Diana, Stalder Grégoire, Tonellotto Luca, Argyriou Pinelopi, Nicod-Lalonde Marie, Schläpfer Aline, 2022/11/08. Rheuma Schweiz Fachzeitschrift, 14 (6) pp. 42-46.
Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization
Camviel Nicolas, Wolf Benita, Croce Giancarlo, Gfeller David, Zoete Vincent, Arber Caroline, 2022/11. Journal for ImmunoTherapy of Cancer, 10 (11) pp. e005091. Peer-reviewed.
 
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment.
Muret C., Crettaz D., Martin A., Aliotta A., Bertaggia Calderara D., Alberio L., Prudent M., 2022/11. Transfusion, 62 (11) pp. 2324-2333. Peer-reviewed.
Significant Progress in CAR T-Cell Therapy for Difficult-to-Treat Hematologic Malignancies
Stadelmann Raphael, Cairoli Anne, Arber Caroline, 2022/10/31. healthbook TIMES Oncology Hematology - Edition 3 / 2022 13. Peer-reviewed.
Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.
Rittener-Ruff L., Marchetti M., Matthey-Guirao E., Grandoni F., Gomez F.J., Alberio L., 2022/10. Journal of thrombosis and haemostasis, 20 (10) pp. 2407-2418. Peer-reviewed.
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
 
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer.
Bai J.F., Majjigapu S.R., Sordat B., Poty S., Vogel P., Elías-Rodríguez P., Moreno-Vargas A.J., Carmona A.T., Caffa I., Ghanem M. et al., 2022/09/05. European journal of medicinal chemistry, 239 p. 114504. Peer-reviewed.
 
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Janssen JJWM, Löwenberg B., Manz M., Biemond B.J., Westerweel P.E., Klein S.K., Fehr M., Sinnige HAM, Efthymiou A., Legdeur MCJC et al., 2022/09. Leukemia, 36 (9) pp. 2189-2195. Peer-reviewed.
 
Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report.
Tsilimidos G., Blum S., Aliotta A., Dumusc A., Alberio L., 2022/09. Current research in translational medicine, 70 (4) p. 103358. Peer-reviewed.
Differential Blood Counts Do Not Consistently Predict Clinical Measurements of Bone Mineral Density and Microarchitecture at Homeostasis.
Schyrr F., Marques-Vidal P., Hans D., Lamy O., Naveiras O., 2022/09. JBMR plus, 6 (9) pp. e10669. Peer-reviewed.
 
Hepatitis B reactivation during ruxolitinib treatment.
Sjoblom M., Chtioui H., Fraga M., Stalder G., Grandoni F., Blum S., 2022/09. Annals of hematology, 101 (9) pp. 2081-2086. Peer-reviewed.
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
 
High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Tschopp J., Brunel A.S., Spertini O., Croxatto A., Lamoth F., Bochud P.Y., 2022/08/25. Clinical infectious diseases, 75 (2) pp. 330-333. Peer-reviewed.
Haematological changes from conception to childbirth: An indicator of major pregnancy complications.
Patxot M., Stojanov M., Ojavee S.E., Pescini Gobert R., Kutalik Z., Gavillet M., Baud D., Robinson M.R., 2022/08. European journal of haematology, 109 (5) pp. 566-575. Peer-reviewed.
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.
Sathanantham V., Alberio L., Bovet C., Fontana P., Gerber B., Graf L., Mendez A., Sauter T.C., Schmidt A., Studt J.D. et al., 2022/07/11. Life, 12 (7) p. 1027. Peer-reviewed.
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
Ghanem M.S., Caffa I., Del Rio A., Franco J., Parenti M.D., Monacelli F., Cea M., Khalifa A., Nahimana A., Duchosal M.A. et al., 2022/07/10. Pharmaceuticals, 15 (7) p. 848. Peer-reviewed.
 
Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.
McGrady M.E., Todd K., Ignjatovic V., Jones S., Rizzi M., Luchtman-Jones L., Thornburg C.D., 2022/07. Journal of thrombosis and haemostasis, 20 (7) pp. 1720-1728. Peer-reviewed.
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Gleich T., Gomez F.J., Goodyer M., Grandoni F., Alberio L., 2022/06. British journal of haematology, 197 (6) pp. 766-790. Peer-reviewed.
Neisseria meningitidis in peripheral blood smear.
Dewarrat N., Bovey F., Kaiser J., Blum S., 2022/06. International journal of laboratory hematology, 44 (3) pp. 444-445. Peer-reviewed.
Pseudoreticulocytosis in a patient with myelodysplastic syndrome.
De Rossi N., Alberio L., Stalder G., 2022/06/01. American journal of hematology, 97 (6) pp. 841-842. Peer-reviewed.
 
Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Boller D., Doepfner K.T., Laurentiis A., Guerreiro A.S., Marinov M., Shalaby T., Depledge P., Robson A., Saghir N., Hayakawa M. et al., 2022/06. Anticancer research, 42 (6) pp. 3217-3230. Peer-reviewed.
Another piece of knowledge in the puzzle of procoagulant COAT platelets.
Aliotta A., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1073-1076. Peer-reviewed.
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.
Segot A., Adler M., Aliotta A., Matthey-Guirao E., Nagler M., Bertaggia Calderara D., Grandoni F., Gomez F.J., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1271-1274. Peer-reviewed.
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
ElMokh O., Matsumoto S., Biniecka P., Bellotti A., Schaeuble K., Piacente F., Gallart-Ayala H., Ivanisevic J., Stamenkovic I., Nencioni A. et al., 2022/04/08. Cell death & disease, 13 (4) p. 320. Peer-reviewed.
 
A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
Huot Anais, Maniu Christa-Maria, Bogiatzi Sofia, Hohl Daniel, Alberio Lorenzo, Stalder Gregoire, 2022/03. JEADV Clinical Practice, 1 (1) pp. 45-48. Peer-reviewed.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
Evolving Treatment Landscape of AML
Blum Sabine, Bacher Ulrike, Pabst Thomas, 2022/03/01. healthbook TIMES Onco Hema. Peer-reviewed.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
Ségot A., Stalder G., de Leval L., Solly F., Schoumans J., Basset V., Blum S., Spertini O., 2022/03/01. American journal of hematology, 97 (3) pp. E91-E93. Peer-reviewed.
Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.
Veuthey L., Aliotta A., Bertaggia Calderara D., Pereira Portela C., Alberio L., 2022/02/25. International journal of molecular sciences, 23 (5) p. 2536. Peer-reviewed.
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
Stalder G., Milowich D., Blum S., Schoumans J., Bisig B., Spertini O., 2022/02. EJHaem, 3 (1) pp. 259-260. Peer-reviewed.
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Amstutz U. et al., 2022. Frontiers in cardiovascular medicine, 9 p. 817826. Peer-reviewed.
Blood coagulation alterations over the first 10 days after severe burn injury
Barbier Jeanne M., Viana Marina V., Pantet Olivier, Alberio Lorenzo, Berger Mette M., 2022/01. Burns Open, 6 (1) pp. 10-18.
 
Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
Pouplard C., Rollin J., Vayne C., Charuel N., Ahmadi Z., Alberio L., Azjenberg N., Althaus K., Bakchoul T., Chong B. et al., 2022/01. Journal of thrombosis and haemostasis, 20 (1) pp. 252-259. Peer-reviewed.
 
Raman microspectroscopy reveals unsaturation heterogeneity at the lipid droplet level and validates an in vitro model of bone marrow adipocyte subtypes.
Tratwal J., Falgayrac G., During A., Bertheaume N., Bataclan C., Tavakol D.N., Campos V., Duponchel L., Daley G.Q., Penel G. et al., 2022. Frontiers in endocrinology, 13 p. 1001210. Peer-reviewed.
Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis.
Cisarovsky C., Théaudin M., Bart P.A., Stalder G., Alberio L., 2022. Case reports in hematology, 2022 p. 2767031. Peer-reviewed.
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
Vecchio M., Guenot C., Staubli S., Gavillet M., Alberio L., Mazzolai L., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2135-2138. Peer-reviewed.
Cryogel-based Injectable 3D Microcarrier Co-culture for Support of Hematopoietic Progenitor Niches.
Tavakol D.N., Bonini F., Tratwal J., Genta M., Brefie-Guth J., Braschler T., Naveiras O., 2021/11. Current protocols, 1 (11) pp. e275. Peer-reviewed.
 
Hypoplastisches myelodysplastisches Syndrom
Grandoni Francesco, Dewarrat Natacha, Blum Sabine, 2021/10/20. InFo Hämatol Onkol , 24 (10) pp. 22-25.
 
An Injectable Meta-Biomaterial: From Design and Simulation to In Vivo Shaping and Tissue Induction.
Béduer A., Bonini F., Verheyen C.A., Genta M., Martins M., Brefie-Guth J., Tratwal J., Filippova A., Burch P., Naveiras O. et al., 2021/10. Advanced materials, 33 (41) pp. e2102350. Peer-reviewed.
 
Anticoagulation of women with congenital heart disease during pregnancy
Rutz Tobias, Eggel-Hort Béatrice, Alberio Lorenzo, Bouchardy Judith, 2021/10. International Journal of Cardiology Congenital Heart Disease, 5 p. 100210.
 
High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/10. Thrombosis and haemostasis, 121 (10) pp. 1337-1344. Peer-reviewed.
 
Successful Rapid Oral Desensitization to Ibrutinib in a Patient With Severe Immediate Hypersensitivity Reaction.
Tsilimidos G., Horisberger A., Ribi C., Cairoli A., Stalder G., 2021/10. Clinical lymphoma, myeloma & leukemia, 21 (10) pp. e745-e747. Peer-reviewed.
Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy.
Robinson M.R., Patxot M., Stojanov M., Blum S., Baud D., 2021/09/28. Scientific reports, 11 (1) p. 19238. Peer-reviewed.
EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT.
Blum S., Malcovati L., 2021/09. HemaSphere, 5 (9) pp. e631. Peer-reviewed.
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
 
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.
Kraljevic M., Khanna N., Medinger M., Passweg J., Masouridi-Levrat S., Chalandon Y., Mueller N.J., Schanz U., Vernaz N., Van Delden C. et al., 2021/07/06. Medical mycology, 59 (7) pp. 701-711. Peer-reviewed.
 
Acute lymphoblastic leukaemia presenting as euglycaemic ketoacidosis in a patient with type 1 diabetes.
Gavillet M., Schaefer N., Lapointe A.K., Spertini O., Cairoli A., 2021/07. The Lancet. Haematology, 8 (7) pp. e534. Peer-reviewed.
Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment.
Tratwal J., Rojas-Sutterlin S., Bataclan C., Blum S., Naveiras O., 2021/07. Best practice & research. Clinical endocrinology & metabolism, 35 (4) p. 101564. Peer-reviewed.
Complex Modes of Inheritance in Hereditary Red Blood Cell Disorders: A Case Series Study of 155 Patients.
Andolfo I., Martone S., Rosato B.E., Marra R., Gambale A., Forni G.L., Pinto V., Göransson M., Papadopoulou V., Gavillet M. et al., 2021/06/23. Genes, 12 (7) p. 958. Peer-reviewed.
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
Willekens G., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2021/06. British journal of haematology, 193 (6) pp. 1203-1212. Peer-reviewed.
 
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Scharf R.E., Alberio L., 2021/06. Hamostaseologie, 41 (3) pp. 179-182. Peer-reviewed.
 
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Koster A., Erdoes G., Nagler M., Birschmann I., Alberio L., 2021/06. Journal of cardiothoracic and vascular anesthesia, 35 (6) pp. 1585-1593. Peer-reviewed.
Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.
Tschopp J., Perentes J.Y., Beigelman-Aubry C., Berezowska S., Lovis A., Spertini O., Bochud P.Y., Lamoth F., 2021/06. Medical mycology case reports, 32 pp. 68-72. Peer-reviewed.
Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.
Voruz S., de Leval L., Cairoli A., 2021/05/13. Experimental hematology & oncology, 10 (1) p. 32. Peer-reviewed.
 
Thrombotic storm under DOAC treatment in a patient with homozygous antithrombin Budapest III mutation.
Condoluci A., Alberio L., Gomez F.J., Studt J.D., Orlando C., Jochmans K., Gerber B., 2021/05. Thrombosis research, 201 pp. 161-163. Peer-reviewed.
 
Recherche d'anticorps anti-PF4/héparine
Parejas Nomie, Alberio Lorenzo, Kraege Vanessa, 2021/04/13. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
 
GTH 2021: The First Online Experience! Useful for Future Meetings?
Alberio L., 2021/04. Hamostaseologie, 41 (2) pp. 100-102. Peer-reviewed.
 
Décompensation cardiaque, arthralgies et prurit généralisé
Tsilimidos Gerasimos, Grandoni Francesco, Blum Sabine, Alberio Lorenzo, Rotman Samuel, Gavillet Mathilde, 2021/03/30. Forum Médical Suisse ‒ Swiss Medical Forum.
Vitamine B12 en pratique : quand tester ? Comment tester ? Et qui substituer ? [Vitamin B12 in practice: When to test ? How to test ? And who should be treated?]
Bruttin J.P., Gilet P., Grandoni F., Alberio L., Favre L., Gavillet M., 2021/03/24. Revue medicale suisse, 17 (731) pp. 582-587. Peer-reviewed.
 
Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review.
Dewarrat N., Gavillet M., Angelillo-Scherrer A., Naveiras O., Grandoni F., Tsakiris D.A., Alberio L., Blum S., 2021/03. Haemophilia, 27 (2) pp. 199-210. Peer-reviewed.
 
Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/03. Thrombosis and haemostasis, 121 (3) pp. 309-321. Peer-reviewed.
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
Kuendgen A., Nomdedeu M., Tuechler H., Garcia-Manero G., Komrokji R.S., Sekeres M.A., Della Porta M.G., Cazzola M., DeZern A.E., Roboz G.J. et al., 2021/03. Leukemia, 35 (3) pp. 835-849. Peer-reviewed.
Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Marchetti M., Alberio L., 2021/02/24. Journal of clinical medicine, 10 (5) p. 894. Peer-reviewed.
 
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Löwenberg B., Pabst T., Maertens J., Gradowska P., Biemond B.J., Spertini O., Vellenga E., Griskevicius L., Tick L.W., Jongen-Lavrencic M. et al., 2021/02/23. Blood advances, 5 (4) pp. 1110-1121. Peer-reviewed.
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.
Marchetti M., Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2021/02/10. Journal of clinical medicine, 10 (4) p. 683. Peer-reviewed.
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS.
Janssen J., Löwenberg B., Manz M., Bargetzi M., Biemond B., Borne PVD, Breems D., Brouwer R., Chalandon Y., Deeren D. et al., 2021/02/07. Cancers, 13 (4) p. 672. Peer-reviewed.
 
Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Batista Mesquita Sauvage A.P., Carle V., Heinis C., Alberio L., 2021/02. Thrombosis and haemostasis, 121 (2) pp. 150-163. Peer-reviewed.
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
Solari D., Alberio L., Ribi C., Grandoni F., Stalder G., 2021/01. TH open, 5 (1) pp. e8-e13. Peer-reviewed.
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Maeder G.M. et al., 2021. Frontiers in cardiovascular medicine, 8 p. 717939. Peer-reviewed.
 
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
Martins F., Kruszewski M., Scarpelli I., Schoumans J., Spertini O., Lübbert M., Blum S., 2021/01. Annals of hematology, 100 (1) pp. 63-78. Peer-reviewed.
 
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>.
Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., Abeliovich H., Abildgaard M.H., Abudu Y.P., Acevedo-Arozena A. et al., 2021/01. Autophagy, 17 (1) pp. 1-382. Peer-reviewed.
Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
Aliotta A., Krüsi M., Bertaggia Calderara D., Zermatten M.G., Gomez F.J., Batista Mesquita Sauvage A.P., Alberio L., 2020/12/14. International journal of molecular sciences, 21 (24) p. 9515. Peer-reviewed.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
Fontana P., Alberio L., Albisetti M., Angelillo-Scherrer A., Asmis L.M., Casini A., Gerber B., Graf L., Hegemann I., Korte W. et al., 2020/12/14. Swiss medical weekly, 150 pp. w20422. Peer-reviewed.
 
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir B.C., Latifyan S., Perreau M., Fenwick C., Alberio L., Waeber G., Spertini F., de Leval L., Michielin O., Obeid M., 2020/12. Annals of oncology, 31 (12) pp. 1775-1778. Peer-reviewed.
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
 
Interprétation du dosage des anticorps anti-phospholipides
Nozic Adnan, Burger Raphael, Alberio Lorenzo, Ribi Camillo, 2020/11/03. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
 
A Collection of Jewels.
Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 399-400. Peer-reviewed.
 
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Chehade H., Cachat F., Beck-Popovic M., Rotman S., Diezi L., Albisetti M., Alberio L., Young G., Rizzi M., 2020/11. Pediatrics, 146 (5) pp. e20200123. Peer-reviewed.
 
How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 491-499. Peer-reviewed.
 
The Art of Detecting Antibodies against Factor VIII.
Tiede A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 485-490. Peer-reviewed.
Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.
Bajwa G., Lanz I., Cardenas M., Brenner M.K., Arber C., 2020/11. Journal for immunotherapy of cancer, 8 (2) pp. e001487. Peer-reviewed.
 
Heavy metal.
Dewarrat N., Blum S., 2020/10/22. Blood, 136 (17) p. 1993. Peer-reviewed.
 
Découverte d’une thrombocytopénie isolée [Finding of an isolated thrombocytopenia]
van Ouwenaller François, Alberio Lorenzo, Garnier Antoine, 2020/10/21. Forum Med Suisse, 20 (43-44) pp. 612-614.
 
Anémie hémolytique chronique dépendante de transfusions
Solari Daria, Grandoni Francesco, Alberio Lorenzo, Renella Raffaele, Gavillet Mathilde, 2020/10/20. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
 
Management of erroneous subcutaneous injection of vincristine.
de Goycoechea D., Dewarrat N., Rothuizen L.E., Matter M., Nagy M., Locher G., Spertini O., Blum S., 2020/10. Leukemia & lymphoma, 61 (10) pp. 2530-2532. Peer-reviewed.
Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study.
Kaufmann J., Adler M., Alberio L., Nagler M., 2020/10. TH open, 4 (4) pp. e427-e436. Peer-reviewed.
MarrowQuant Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.
Tratwal J., Bekri D., Boussema C., Sarkis R., Kunz N., Koliqi T., Rojas-Sutterlin S., Schyrr F., Tavakol D.N., Campos V. et al., 2020/09/24. Frontiers in endocrinology, 11 p. 480. Peer-reviewed.
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Huls G., Chitu D.A., Pabst T., Klein S.K., Stussi G., Griskevicius L., Valk PJM, Cloos J., van de Loosdrecht A.A., Breems D. et al., 2020/09/22. Blood advances, 4 (18) pp. 4267-4277. Peer-reviewed.
Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report.
Salvioni Chiabotti P., Bisig B., Cairoli A., Hajdu S.D., Lovey P.Y., Milowich D., Ziadi S., Du Pasquier R., Brouland J.P., de Leval L., 2020/09/14. Frontiers in oncology, 10 p. 1745. Peer-reviewed.
 
Flow Cytometric Monitoring of Dynamic Cytosolic Calcium, Sodium, and Potassium Fluxes Following Platelet Activation.
Aliotta A., Bertaggia Calderara D., Alberio L., 2020/09. Cytometry. Part A, 97 (9) pp. 933-944. Peer-reviewed.
 
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Blum S., Dunet V., Comoli P., Tirefort Y., Chalandon Y., Opota O., Comte D., Spertini O., Livio F., Brouland J.P. et al., 2020/09. Leukemia & lymphoma, 61 (9) pp. 2226-2229. Peer-reviewed.
 
Anticoagulants directs
Krähenbühl Marie, Alberio Lorenzo, Kraege Vanessa, 2020/08/26. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
Stalder G., Alberio L., 2020/08/13. Blood, 136 (7) p. 915. Peer-reviewed.
 
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.
Benz R., Arn K., Andres M., Pabst T., Baumann M., Novak U., Hitz F., Hess U., Zenhaeusern R., Chalandon Y. et al., 2020/08/11. Blood advances, 4 (15) pp. 3699-3707. Peer-reviewed.
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
Zermatten M.G., Fraga M., Calderara D.B., Aliotta A., Moradpour D., Alberio L., 2020/08. JHEP reports, 2 (4) p. 100120. Peer-reviewed.
 
Potential and Limitations of the New P2Y12 Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study.
Scala E., Gerschheimer C., Gomez F.J., Alberio L., Marcucci C., 2020/08. Anesthesia and analgesia, 131 (2) pp. 622-630. Peer-reviewed.
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
Stavropoulou E., Coste A.T., Beigelman-Aubry C., Letovanec I., Spertini O., Lovis A., Krueger T., Burger R., Bochud P.Y., Lamoth F., 2020/07/22. BMC infectious diseases, 20 (1) p. 527. Peer-reviewed.
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
Artru F., Alberio L., Moradpour D., Stalder G., 2020/07/07. BMJ case reports, 13 (7) pp. e236815. Peer-reviewed.
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4<sup>+</sup> T cells.
Rath J.A., Bajwa G., Carreres B., Hoyer E., Gruber I., Martínez-Paniagua M.A., Yu Y.R., Nouraee N., Sadeghi F., Wu M. et al., 2020/07. Science advances, 6 (27) pp. eaaz7809. Peer-reviewed.
Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
Giangrande Paul, Abdul Karim Faraizah, Nemes Laszlo, You Chur Woo, Landorph Andrea, Geybels Milan S., Curry Nicola, 2020/06/16. Journal of Thrombosis and Haemostasis.
Combined Lung and Liver Transplantation for Short Telomere Syndrome.
Moschouri E., Vionnet J., Giostra E., Daccord C., Lazor R., Sciarra A., Letovanec I., Sempoux C., Gonzalez M., Unger S. et al., 2020/06. Liver transplantation, 26 (6) pp. 840-844. Peer-reviewed.
 
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.
Gerber A., Da Silva Lopes A., Szüts N., Simon M., Ribordy-Baudat V., Ebneter A., Perrinjaquet C., Gaignard M.E., Nicodet D., Betticher D. et al., 2020/06. Health science reports, 3 (2) pp. e160. Peer-reviewed.
 
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
Zermatten M.G., Fraga M., Moradpour D., Bertaggia Calderara D., Aliotta A., Stirnimann G., De Gottardi A., Alberio L., 2020/06. Hepatology, 71 (6) pp. 2135-2148. Peer-reviewed.
 
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Gavillet M., Rolnik D.L., Hoffman M.K., Panchaud A., Baud D., 2020/06. Ultrasound in obstetrics & gynecology, 55 (6) pp. 843-844. Peer-reviewed.
An international registry for emergent pathogens and pregnancy.
Panchaud A., Favre G., Pomar L., Vouga M., Aebi-Popp K., Baud D., COVI-Preg group, 2020/05/09. Lancet, 395 (10235) pp. 1483-1484. Peer-reviewed.
 
Functional characterization of the first missense variant in CEP78, a founder allele associated with cone-rod dystrophy, hearing loss, and reduced male fertility.
Ascari G., Peelman F., Farinelli P., Rosseel T., Lambrechts N., Wunderlich K.A., Wagner M., Nikopoulos K., Martens P., Balikova I. et al., 2020/05. Human mutation, 41 (5) pp. 998-1011. Peer-reviewed.
COVID-19, une approche polyphonique.
Blum S., Gavillet M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) p. 809. Peer-reviewed.
 
L’hématologie au temps du COVID-19 [Hematology in the time of COVID-19]
Gavillet M., Rufer N., Grandoni F., Carr Klappert J., Zermatten M.G., Cairoli A., Canellini G., Alberio L., Duchosal M.A., Spertini O. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 823-826. Peer-reviewed.
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.
Alberio L., Angelillo-Scherrer A., Asmis L., Casini A., Fontana P., Graf L., Hegemann I., Kremer Hovinga J.A., Korte W., Lecompte T. et al., 2020/04/20. Swiss medical weekly, 150 pp. w20210. Peer-reviewed.
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Casini A., Alberio L., Angelillo-Scherrer A., Fontana P., Gerber B., Graf L., Hegemann I., Korte W., Kremer Hovinga J., Lecompte T. et al., 2020/04/06. Swiss medical weekly, 150 pp. w20247. Peer-reviewed.
 
Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Zermatten M.G., Monnin-Respen F., Matthey-Guirao E., Nicolas N., Gomez F., Goodyer M., Gerschheimer C., Alberio L., 2020/04/02. Blood, 135 (14) pp. 1171-1184. Peer-reviewed.
Acute leukemia in the time of COVID-19.
Gavillet M., Carr Klappert J., Spertini O., Blum S., 2020/03/26. Leukemia research, 92 p. 106353. Peer-reviewed.
 
Comparison of ROTEM Sigma to Standard Laboratory Tests and Development of an Algorithm for the Management of Coagulopathic Bleeding in a Tertiary Center.
Scala E., Coutaz C., Gomez F., Alberio L., Marcucci C., 2020/03. Journal of cardiothoracic and vascular anesthesia, 34 (3) pp. 640-649. Peer-reviewed.
 
Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters.
Bertaggia Calderara D., Aliotta A., Zermatten M.G., Kröll D., Stirnimann G., Alberio L., 2020/03. Thrombosis research, 187 pp. 91-102. Peer-reviewed.
 
Risk of B-cell lymphoma in MPN patients treated with JAK1/2 inhibitors: Contradictory results?
Costanza M., Spertini O., Blum S., 2020/03. Leukemia research, 90 p. 106313. Peer-reviewed.
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report.
Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2020/03. Research and practice in thrombosis and haemostasis, 4 (3) pp. 429-432. Peer-reviewed.
Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis.
Tavakol D.N., Tratwal J., Bonini F., Genta M., Campos V., Burch P., Hoehnel S., Béduer A., Alessandrini M., Naveiras O. et al., 2020/02. Biomaterials, 232 p. 119665. Peer-reviewed.
 
Rivaroxaban in patients with mechanical heart valves: A pilot study.
Roost E., Weber A., Alberio L., Englberger L., Reineke D., Keller D., Nagler M., Carrel T., 2020/02. Thrombosis research, 186 pp. 1-6. Peer-reviewed.
Targeting mitochondria to stimulate hematopoiesis.
Girotra M., Naveiras O., Vannini N., 2020/01/28. Aging, 12 (2) pp. 1042-1043. Peer-reviewed.
 
Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.
Brodard J., Alberio L., Angelillo-Scherrer A., Nagler M., 2020/01. Thrombosis research, 185 pp. 27-30. Peer-reviewed.
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring "Universal" Donor T Cells.
Perez C., Gruber I., Arber C., 2020. Frontiers in immunology, 11 p. 583716. Peer-reviewed.
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
 
Pregnancy with Chuvash Polycythaemia and Other Congenital Erythrocytosis.
Dewarrat N., Kaiser J., Baud D., Alberio L., Gavillet M., 2020. Acta haematologica, 143 (1) pp. 69-72. Peer-reviewed.
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society.
Tratwal J., Labella R., Bravenboer N., Kerckhofs G., Douni E., Scheller E.L., Badr S., Karampinos D.C., Beck-Cormier S., Palmisano B. et al., 2020. Frontiers in endocrinology, 11 p. 65. Peer-reviewed.
 
Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry.
Girotra M., Thierry A.C., Harari A., Coukos G., Naveiras O., Vannini N., 2019/12/26. Journal of visualized experiments 154. Peer-reviewed.
Successful desensitization to pomalidomide in a patient with POEMS syndrome with delayed-type hypersensitivity to immunomodulatory imid drugs.
Grandoni F., Stalder G., Borgeat Kaeser A., Ribi C., Cairoli A., Blum S., 2019/12. Leukemia & lymphoma, 60 (12) pp. 3087-3089. Peer-reviewed.
 
The function of P-selectin glycoprotein ligand-1 is conserved from ancestral fishes to mammals.
Baïsse B., Spertini C., Galisson F., Smirnova T., Spertini O., 2019/12. Journal of leukocyte biology, 106 (6) pp. 1271-1283. Peer-reviewed.
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux A.J., Aubry D., Heulot M., Widmann C., ElMokh O., Piacente F., Cea M., Nencioni A., Bellotti A., Bouzourène K. et al., 2019/11/19. Oncotarget, 10 (62) pp. 6723-6738. Peer-reviewed.
 
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia.
Scala E., Pitta-Gros B., Pantet O., Iafrate M., Kirsch M., Marcucci C., Alberio L., 2019/11. Journal of cardiothoracic and vascular anesthesia, 33 (11) pp. 3073-3077. Peer-reviewed.
 
La TEVAR, un traitement durable des thrombi mobiles de l'aorte descendante?
Kohler Corinne, Wyss Thomas Rudolf, Alberio Lorenzo, Schmidli Jrg, Bhlmann Roman, 2019/10/09. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
Davis J., Yan S., Matsushita T., Alberio L., Bassett P., Santagostino E., 2019/10. Journal of medical economics, 22 (10) pp. 1014-1021. Peer-reviewed.
 
Fungal spore contamination mimicking parasitic infection.
Blum S., Cairoli A., 2019/09/05. Blood, 134 (10) p. 841. Peer-reviewed.
 
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43.
Spertini C., Baïsse B., Bellone M., Gikic M., Smirnova T., Spertini O., 2019/08/27. Cancers, 11 (9). Peer-reviewed.
Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.
Hallak B., Cairoli A., Bouayed S., Berthod G., 2019/08/13. BMJ case reports, 12 (8). Peer-reviewed.
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
Silzle T., Blum S., Schuler E., Kaivers J., Rudelius M., Hildebrandt B., Gattermann N., Haas R., Germing U., 2019/08/09. Blood cancer journal, 9 (8) p. 63. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University